cached image

Richard Mulligan

Affiliations: 
Harvard Medical School, Boston, MA, United States 
Area:
Gene therapy
Website:
http://www.hsci.harvard.edu/people/richard-c-mulligan-phd
Google:
"Richard Mulligan"
Mean distance: 8.08 (cluster 21)
 
SNBCP
Cross-listing: Cell Biology Tree - Cell & Gene Therapy Tree

Parents

Sign in to add mentor
Alexander Rich research assistant MIT
Paul Berg grad student 1981 Stanford
 (Transduction of genes into animal cells)
David Baltimore post-doc MIT
Phillip Allen Sharp post-doc MIT

Children

Sign in to add trainee
Roger  D. Cone grad student 1986 MIT
Alejandro B. Balazs grad student 2006 Harvard
Jacob W. Ulm grad student 2006 Harvard
Constance L. Cepko post-doc Harvard (Neurotree)
Olivier Danos post-doc Harvard Medical School/Whitehead Institute (Cell & Gene Therapy Tree)
Michel Sadelain post-doc Whitehead Institute for Biomedical Research (Cell & Gene Therapy Tree)
David A. Sanders post-doc (Cell & Gene Therapy Tree)
David A. Williams post-doc Harvard Medical School
James  M. Wilson post-doc Broad Institute (MIT/Harvard) (Cell & Gene Therapy Tree)
Margaret A. Goodell post-doc 1991-1997 Baylor (Cell Biology Tree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mulligan RC. (2014) Development of gene transfer technology. Human Gene Therapy. 25: 995-1002
Burkhardt UE, Hainz U, Stevenson K, et al. (2013) Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells. The Journal of Clinical Investigation. 123: 3756-65
Brusic A, Hainz U, Wadleigh M, et al. (2012) Detecting T-cell reactivity to whole cell vaccines: Proof of concept analysis of T-cell response to K562 cell antigens in CML patients. Oncoimmunology. 1: 1095-1103
Herson S, Hentati F, Rigolet A, et al. (2012) A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C. Brain : a Journal of Neurology. 135: 483-92
Schwenter F, Zarei S, Luy P, et al. (2011) Cell encapsulation technology as a novel strategy for human anti-tumor immunotherapy. Cancer Gene Therapy. 18: 553-62
Sahin E, Colla S, Liesa M, et al. (2011) Telomere dysfunction induces metabolic and mitochondrial compromise. Nature. 470: 359-65
Sanchez CE, Tierney TS, Gale JT, et al. (2011) Recombinant adeno-associated virus type 2 pseudotypes: comparing safety, specificity, and transduction efficiency in the primate striatum. Laboratory investigation. Journal of Neurosurgery. 114: 672-80
Danos O, Davies K, Lehn P, et al. (2010) The ARRIVE guidelines, a welcome improvement to standards for reporting animal research. The Journal of Gene Medicine. 12: 559-60
Wilson AA, Murphy GJ, Hamakawa H, et al. (2010) Amelioration of emphysema in mice through lentiviral transduction of long-lived pulmonary alveolar macrophages. The Journal of Clinical Investigation. 120: 379-89
Bullain SS, Sahin A, Szentirmai O, et al. (2009) Genetically engineered T cells to target EGFRvIII expressing glioblastoma. Journal of Neuro-Oncology. 94: 373-82
See more...